Mondido, Rogelyn G.

HRN: 25-47-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/12/2024
07/19/2024
IV
200mg
Q8hours
T/c Dengue Hemorrhagic Fever
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: